Joint Research Office


Consultation on legislative changes for clinical trials

27 January 2022

The MHRA is consulting on proposals to improve UK clinical trials legislation aimed at making the UK the best place to do research.

The ambition is to streamline clinical trials approvals, enable innovation, enhance clinical trials transparency, enable greater risk proportionality, and promote patient and public involvement in clinical trials.

The JRO will be submitting a response to the consultation on behalf of UCL, and welcomes input into this response from researchers and research with an interest and relevant expertise.

To input into the UCL consultation response, please review and provide answers to the questions in this internal UCL survey.

The deadline for responses to this internal survey is 22 February 2022.

Details of the consultation are on the UK government website. Researchers and research staff are welcome to submit individuals responses to the consultation.